$AMN

Spotting Winners: AMN Healthcare Services (NYSE:AMN) And Healthcare Providers & Services Stocks In Q2

A Q2 earnings wrap for 39 healthcare providers and services stocks says group revenues beat analysts’ consensus by 1.7% and next-quarter guidance was 1.6% above. It highlights AMN Healthcare Services (AMN) revenue of $673.2M (+2.3% YoY), beating estimates by 7.2%, and stock up 11.7% to $34.41. Other featured names include CVS, AdaptHealth, McKesson, and Encompass Health.

Original reporting
Published Aug 17, 2026, 7:04 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 17, 2026, 2:51 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Spotting Winners: AMN Healthcare Services (NYSE:AMN) And Healthcare Providers & Services Stocks In Q2 — source image
Decision brief

The 30-second read

$AMNBullishLow
01

Why it matters

For AMN, the only actionable takeaway is that reported revenue and guidance beat consensus, with the stock up since the report; however, there is no new guidance update or event beyond the earnings recap.

02

Market read

A sector earnings recap with specific AMN beat metrics and post-earnings price reaction, but no fresh catalyst beyond the reported quarter.

03

What to watch

The piece does not quantify margin, labor cost trends, or reimbursement changes, which are key drivers for healthcare staffing and services valuation.

Relevance 4/10Novelty 3/10Timing: after Q2 earnings reporting, stock performance since results

Background

The article is a multi-stock wrap of Q2 earnings for healthcare providers and services, highlighting beats/misses versus consensus and subsequent stock moves.

Company-level read

Ticker impact

$AMNBullishMedium confidence
Context

AMN Healthcare reported Q2 revenue of $673.2M (+2.3% YoY) and beat analysts’ expectations by 7.2%, with next-quarter guidance also above consensus.

Expected impact

Near-term bias modestly positive versus peers, but follow-through depends on whether the market already priced the beat.

Evidence & confidence

It cites specific Q2 and guidance beats plus the stock being up 11.7% since reporting, but the piece is essentially a recap of already-reported earnings rather than a fresh disclosure.

Market effects

Sector-wide framing suggests continued demand but persistent reimbursement and labor-cost pressure; no new policy or regulatory change is disclosed.

No regional market-specific catalyst is provided.

No global macro or cross-border healthcare policy catalyst is provided.

Counterpoint

AMN’s guidance raise may already be priced, and the article notes shares are “relatively unchanged” on average across the group, implying limited incremental upside.

Key entities

  • AMN Healthcare Services

    Healthcare workforce solutions provider; Q2 revenue and guidance beat consensus per the article.

  • CVS Health

    Pharmacy and PBM operator; Q2 results beat consensus but stock is down since reporting per the article.

  • AdaptHealth

    Home medical equipment provider; Q2 results missed consensus and stock is down sharply per the article.

  • McKesson

    Pharmaceutical distributor; Q2 revenue beat and stock slightly down per the article.

  • Encompass Health

    Inpatient rehab hospital operator; Q2 revenue and EPS guidance beats with stock up per the article.

Related articles

$AMNMed

AMN Healthcare Adds AI Interpreting as Prices Squeezed

AMN Healthcare reported Q2 2026 language services revenue of $69.6m, down 8% YoY due to pricing pressure. Overall revenue rose 2% to $673.2m, with net income at $21.2m. The company acquired Jaide Health for AI interpreting services and expects Q3 revenue of $640m-$655m.

$AMNMedAI 9/10

AMN Healthcare (AMN) Q2 2026 Earnings Call Transcript

AMN Healthcare reported Q2 2026 revenue of $673 million, up 2% year over year and 6% above the top end of guidance, with adjusted EPS of $0.77. Adjusted EBITDA was $73 million (10.9% margin) after $27 million in nonrecurring billing true-ups. Q3 revenue guidance is $640 million to $655 million. AMN also authorized share repurchases and acquired Jaide Health and ESSENTIAL.

$AMNMedAI 8/10

5 Revealing Analyst Questions From AMN Healthcare Services’s Q2 Earnings Call

AMN Healthcare Services reported Q2 revenue of $673.2 million, above analysts’ $628.2 million estimate, and adjusted EPS of $0.77 versus $0.19. Management attributed results to strong Nurse and Allied Solutions demand, including travel nurse and allied volumes, plus higher labor disruption revenue and improved search and international execution. Q3 revenue guidance midpoint was $647.5 million.

$AMNHighAI 9/10

AMN HEALTHCARE ANNOUNCES SECOND QUARTER 2026 RESULTS

AMN Healthcare Services (NYSE: AMN) reported Q2 2026 revenue of $673 million, up 2% year over year, and adjusted EBITDA of $73 million. GAAP net income was $21 million, or $0.53/share, and adjusted EPS was $0.77. The company said results exceeded guidance, citing travel nurse and allied growth, 27% search revenue growth, and acquisitions expanding AI and leadership offerings. Q3 revenue is expected 1-3% higher.